Skip Navigation Links
An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease
Overall Recruitment Status: Active, currently enrolling
 
Official Title
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects With Moderate to Severe Crohn's Disease
 
Region Sponsors
Colorado
Bristol-Myers Squibb Pharmaceuticals
 
Acronym KP IRB No.
1450316
 
Study Type Phase
Clinical Trial Phase II
 
Study Population Description
Individuals with documented diagnosis of Granulomatous Colitis, Crohn's Disease, Crohn's Enteritis, Granulomatous Enteritis
 
Purpose
This is an investigational study, also known as LATTICE-CD, of the experimental medication BMS-986165 in participants with moderate to severe Crohn's Disease, a chronic bowel disease that causes severe inflammation of the digestive tract.
 
Detailed Description
 
Gender Age Limit
Male & Female 18 - 75 years
 
Inclusion Criteria
  • For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
  • Documented diagnosis of Crohn's Disease for at least 3 months
  • Please contact study team for more eligibility criteria
 
Exclusion Criteria
  • Severe or fulminant colitis that is likely to require surgery or hospitalization
  • Presence of a diagnosis of alternative forms of colitis (infectious, inflammatory including ulcerative colitis, malignant, toxic, indeterminate, etc.) other than Crohn's Disease
  • Other protocol defined inclusion/exclusion criteria could apply
  • Please contact study team for more eligibility criteria

 
Keywords and/or Specific Medical Conditions
  • BMS-986165
  • Gastrointestinal Diseases
  • Crohn Disease
  • Inflammatory Bowel Diseases
  • Dermatologic Agents
  • Intestinal Diseases
  • Digestive System Diseases
  • Molecular Mechanisms of Pharmacological Action
  • Enteritis
  • Protein Kinase Inhibitors
  • Enzyme Inhibitors
  • Gastroenterology
  • Gastroenteritis
 
KP Clinical Facility
  • Lone Tree Medical Offices - Lone Tree
 
Clinical Area
  • Gastroenterology


Principal Investigator:
Christopher Shepela, MD
Contact Information:
- Kristi Bronkan, PharmD
-303) 720-2685
-kristi.m.bronkan@kp.org
-Lone Tree Medical Offices - Lone Tree
- Kristi M Bronkan, PharmD
-303-720-2685
-Lone Tree Medical Offices - Lone Tree
-http://kpco-ihr.org/Research/Clinical_Trials.html


smilelady1
Do you want to receive
Email Alerts?

Sign Up Here!





Regional Research Sites: